Neuroscience & Outreach

⏱️ 3 min read

📍 Madrid (UCM)

A Milestone in Neuroscience: Luis Carlos Fernández Beltrán's PhD Thesis Unveils Cholesterol's Role in ALS

Scientific excellence and pride are at an all-time high at Scorrochano Lab! The Nova Mentis Fellowships—an initiative dedicated to empowering outstanding young biomedical researchers—have unveiled their inaugural awardees. Among them, our colleague Luis Carlos Fernández Beltrán has been recognized for his extraordinary doctoral thesis: “Study of lipid alterations in the hSOD1G93A murine model and the modulation of cholesterol metabolism as a therapeutic target”.

💡 Key Takeaways

  • Nova Mentis Fellowship Winner: Luis Carlos Fernández Beltrán receives prestigious funding supporting the dissemination of his doctoral work.
  • Lipid Dysregulation in ALS: Demonstrates that cholesterol metabolism is profoundly perturbed in the standard hSOD1G93A motor neuron disease model.
  • A Novel Therapeutic Target: Proposes pharmacological and metabolic fine-tuning of brain cholesterol as a viable avenue to preserve motor neurons.

The Biological Heart of the Thesis: Cholesterol and Motor Neuron Survival

Amyotrophic Lateral Sclerosis (ALS) causes the progressive destruction of motor neurons, leading to loss of mobility, speech, and respiratory function. Decades of research have explored protein aggregation and excitotoxicity, but Luis Carlos focused his scientific lens on an often-overlooked dimension: lipid biochemistry.

While cholesterol is frequently associated with cardiovascular health in peripheral tissues, it is an absolute cornerstone of the central nervous system. The brain holds nearly 25% of the body’s total unesterified cholesterol. It is crucial for synaptic neurotransmission, membrane microdomains (lipid rafts), and axonal myelination.

Investigating the gold-standard hSOD1G93A mouse model, Luis Carlos discovered that cholesterol biosynthesis, trafficking, and turnover are dramatically altered long before overt motor symptoms occur. His findings suggest that lipid imbalance is not merely a passive byproduct of dying neurons, but an active, driving factor in neurodegenerative vulnerability. Most excitingly, his thesis demonstrates that modulating these metabolic pathways can confer neuroprotection to motor neurons.

Scientific and Clinical Significance: Opening Untapped Therapeutic Horizons

This achievement delivers immense biomedical value:
Novel Drug Repurposing & Discovery: Identifying the enzymes and nuclear receptors that regulate central cholesterol opens fresh avenues for pharmaceutical intervention in ALS.
Biomarker Development: Measuring specific lipid derivatives (such as oxysterols) in biological fluids could serve as valuable progression markers.
Validating Young Talent: Demonstrates that rigorous academic mentoring at Scorrochano Lab produces top-tier translational neuroscience recognized by independent scientific foundations.

Inspiring Future Generations of Neuroscientists

The Nova Mentis award stands as a testament to Luis Carlos’s perseverance, technical excellence, and dedication. Moments like these inspire our entire team to continue probing the deepest mysteries of brain metabolism. Congratulations Luis Carlos, and forward into the future of neuroscience!

Passionate about neuroscience as much as we are?

Don’t miss any breakthrough from Scorrochano Lab! Follow us on Instagram to discover daily lab life, conference updates, and our latest scientific findings.



Follow us on @scorrochanolab